This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Parent-Adolescent Interactions and Adolescent Development (PAIT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Tara M. Chaplin, Ph.D., George Mason University
ClinicalTrials.gov Identifier:
NCT01572441
First received: April 3, 2012
Last updated: February 23, 2017
Last verified: February 2017
  Purpose
The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.

Condition
Substance Abuse

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.

Resource links provided by NLM:


Further study details as provided by Tara M. Chaplin, Ph.D., George Mason University:

Primary Outcome Measures:
  • Substance Use [ Time Frame: Baseline ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 6 month follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 1 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 2 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 3 year follow-up ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.


Biospecimen Retention:   Samples With DNA
Retain saliva sample.

Estimated Enrollment: 250
Study Start Date: September 2009
Estimated Study Completion Date: July 2018
Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts
12-14 year olds
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.

Detailed Description:
The study examines parenting behaviors and adolescent emotional responses during parent-adolescent interactions and whether these predict youth's current and future substance use over a 3 year follow-up.
  Eligibility

Ages Eligible for Study:   12 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
12-14 year olds and their primary caregivers.
Criteria

Inclusion Criteria:

  • Adolescent between ages 12-14 years

Exclusion Criteria:

  • For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write.
  • Evidence of a psychotic disorder for parent or adolescent
  • Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening.
  • For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening.
  • For adolescent and parent, inadequate English proficiency to comprehend task instructions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01572441

Locations
United States, Connecticut
Yale Stress Center
New Haven, Connecticut, United States, 06520
United States, Virginia
George Mason University
Fairfax, Virginia, United States, 22030
Sponsors and Collaborators
George Mason University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Tara Chaplin, Ph.D. Yale University
  More Information

Publications:
Responsible Party: Tara M. Chaplin, Ph.D., Assistant Professor of Psychology, George Mason University
ClinicalTrials.gov Identifier: NCT01572441     History of Changes
Other Study ID Numbers: 0909005677
R01DA033431 ( U.S. NIH Grant/Contract )
Study First Received: April 3, 2012
Last Updated: February 23, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: We will make data from the proposed laboratory study available to other researchers, after de-identifying study data and after publishing the main manuscripts on the study.

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 22, 2017